News about Global Pharma

Formosa Laboratories Acquires Synchem to Expand in North America

Formosa Laboratories, Inc. has completed its acquisition of SynChem, Inc., a contract research laboratory located in suburban Chicago.

Global Pharma | 03/06/2024 | By Aishwarya |  814

ASPA Organizes Global Meet at Drupa 24 for Authentication and Traceability Professionals

The Authentication Solution Providers' Association (ASPA) has made its entry into the Middle East and Africa regions with the introduction of its MEA (Middle East & Africa) Chapter.

Global Pharma | 03/06/2024 | By Aishwarya |  993

DefiniGEN and Atelerix to Ship In Vitro Cell Models Internationally

DefiniGEN Ltd. and Atelerix Ltd. have successfully shipped in vitro liver models from the UK to a top-tier pharma customer in the US.

Global Pharma | 03/06/2024 | By Aishwarya |  241

Parse Biosciences Unveils Trailmaker Data Analysis Platform

Parse Biosciences has introduced Trailmaker, its user-friendly cloud platform purpose-built for single cell data analysis.

Global Pharma | 03/06/2024 | By Aishwarya |  402

Rgenta Therapeutics Presents Preclinical Data at ASCO 2024

Rgenta Therapeutics has showcased its preclinical data at ASCO 2024 from its lead program, RGT-61159, which is being developed for the potential treatment of adenoid cystic carcinoma (ACC), colorectal cancer (CRC) and other solid tumors as well as acute myeloid leukemia (AML).

Global Pharma | 01/06/2024 | By Aishwarya |  880

Catalyst Oncology and Imerman Angels Announce Collaboration

Catalyst Oncology, the biotech-focused oncology CRO brand of Catalyst Clinical Research, will start a collaboration with Imerman Angels, a renowned nonprofit organization providing free, personalized one-on-one cancer support.

Global Pharma | 31/05/2024 | By Manvi |  467

TOOsonix Gets MDR CE Mark for its New Oncology and Dermatology Device

The certification allows TOOsonix to sell its flagship product, System ONE-M™, across the European Economic Area. Treatment of skin cancer and skin diseases can now be conducted in ways never before possible, providing more patient-friendly treatment than traditional procedures.

Global Pharma | 31/05/2024 | By Manvi |  305

Stevanato Group Inaugurates New Plant in Cisterna di Latina

Stevanato Group has recently launched its Cisterna di Latina plant.

Global Pharma | 31/05/2024 | By Aishwarya |  814

Sanofi Announces Complete Acquisition of Inhibrx

Sanofi has recently announced the complete acquisition of Inhibrx, Inc.

Global Pharma | 31/05/2024 | By Aishwarya |  324

Merck Signs MoU with KAIST to Boost Scientific Research

Merck has signed a non-binding Memorandum of Understanding (MoU) with the Korea Advanced Institute of Science and Technology (KAIST).

Global Pharma | 31/05/2024 | By Aishwarya |  402